Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manja Meggendorfer

Showing results (71-80 of 125) with videos related to

Pageof 13
Sort By:
Genes, Chromosomes & Cancer|January 18, 2018
Incidence and prognostic impact of cytogenetic aberrations in patients with systemic mastocytosisNicole Naumann, Mohamad Jawhar, Juliana Schwaab, et al.
Ebiomedicine|May 26, 2022
Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5qVera Adema, Laura Palomo, Wencke Walter, et al.
Haematologica|November 23, 2023
Massive parallel sequencing unveils homologous recombination deficiency in follicular dendritic cell sarcomaLuisa Lorenzi, Torsten Haferlach, Luigi Mori, et al.
Blood Advances|September 2, 2021
Single- and double-hit events in genes encoding immune targets before and after T cell-engaging antibody therapy in MMMarietta S Truger, Johannes Duell, Xiang Zhou, et al.
Leukemia|January 8, 2025
A novel prognostic risk model for patients with refractory/relapsed acute myeloid leukemia receiving venetoclax plus hypomethylating agentsRabia Shahswar, Razif Gabdoulline, Katja Krueger, et al.
Blood|August 21, 2013
Comprehensive mutational profiling in advanced systemic mastocytosisJuliana Schwaab, Susanne Schnittger, Karl Sotlar, et al.
Leukemia|June 27, 2022
Rare germline alterations of myeloperoxidase predispose to myeloid neoplasmsSunisa Kongkiatkamon, Laila Terkawi, Yihong Guan, et al.
Blood Cancer Discovery|March 8, 2021
A Therapeutic Strategy for Preferential Targeting of TET2 Mutant and TET-dioxygenase Deficient Cells in Myeloid NeoplasmsYihong Guan, Anand D Tiwari, James G Phillips, et al.
Nature Communications|February 28, 2024
Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targetingYasuo Kubota, Xiaorong Gu, Laila Terkawi, et al.
Blood|September 22, 2025
Telomere content and genomics of myeloid neoplasia by whole-genome sequencingLuca Guarnera, Adam Wahida, Carmelo Gurnari, et al.
Pageof 13

Showing results (71-80 of 125) with videos related to

Sort By:
Pageof 13
Genes, Chromosomes & Cancer|January 18, 2018
Incidence and prognostic impact of cytogenetic aberrations in patients with systemic mastocytosisNicole Naumann, Mohamad Jawhar, Juliana Schwaab, et al.
Ebiomedicine|May 26, 2022
Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5qVera Adema, Laura Palomo, Wencke Walter, et al.
Haematologica|November 23, 2023
Massive parallel sequencing unveils homologous recombination deficiency in follicular dendritic cell sarcomaLuisa Lorenzi, Torsten Haferlach, Luigi Mori, et al.
Blood Advances|September 2, 2021
Single- and double-hit events in genes encoding immune targets before and after T cell-engaging antibody therapy in MMMarietta S Truger, Johannes Duell, Xiang Zhou, et al.
Leukemia|January 8, 2025
A novel prognostic risk model for patients with refractory/relapsed acute myeloid leukemia receiving venetoclax plus hypomethylating agentsRabia Shahswar, Razif Gabdoulline, Katja Krueger, et al.
Blood|August 21, 2013
Comprehensive mutational profiling in advanced systemic mastocytosisJuliana Schwaab, Susanne Schnittger, Karl Sotlar, et al.
Leukemia|June 27, 2022
Rare germline alterations of myeloperoxidase predispose to myeloid neoplasmsSunisa Kongkiatkamon, Laila Terkawi, Yihong Guan, et al.
Blood Cancer Discovery|March 8, 2021
A Therapeutic Strategy for Preferential Targeting of TET2 Mutant and TET-dioxygenase Deficient Cells in Myeloid NeoplasmsYihong Guan, Anand D Tiwari, James G Phillips, et al.
Nature Communications|February 28, 2024
Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targetingYasuo Kubota, Xiaorong Gu, Laila Terkawi, et al.
Blood|September 22, 2025
Telomere content and genomics of myeloid neoplasia by whole-genome sequencingLuca Guarnera, Adam Wahida, Carmelo Gurnari, et al.
Pageof 13